Recombinant Human Choriogonadotropin (r-hCG)

DRUG4 trials

Sponsors

EMD Serono, Merck KGaA, Darmstadt, Germany

Conditions

Infertile Women Undergoing Assisted Reproductive Technology (ART)InfertilityOvulation InductionPolycystic Ovarian Syndrome

Phase 2

A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age

TerminatedNCT01079949

Merck KGaA, Darmstadt, GermanyInfertility, Ovulation Induction

Start: 2007-11-30End: 2010-10-31Updated: 2014-02-27

Phase 3

A Phase 3b Study to Evaluate Subject Satisfaction With Follitropin Alfa Injection in Oligoanovulatory Infertile Women Undergoing Ovulation Induction

CompletedNCT00230815

EMD SeronoInfertility

Start: 2004-07-31End: 2005-11-30Updated: 2013-11-28

Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART)

CompletedNCT01185704

Merck KGaA, Darmstadt, GermanyPolycystic Ovarian Syndrome

Start: 2008-11-30End: 2012-02-29Updated: 2014-02-13

Phase 4

A Study to Compare the Safety and Efficacy of Cetrotide® 3 Milligram (mg) Versus Antagon™ in Women Undergoing Ovarian Stimulation

CompletedNCT00298025

EMD SeronoInfertile Women Undergoing Assisted Reproductive Technology (ART)

Start: 2003-09-30End: 2004-05-31Updated: 2014-03-26